Becky A., 1

Becky is a one-year-ten-month-old girl living with her family in Kabura village. She is cheerful, active, and very attentive to the people around her. She is the youngest of three children. On Friday, Becky developed a fever and began vomiting. Her mother administered paracetamol to ease the symptoms, but there was no improvement. Concerned, she brought Becky to the hospital for further evaluation and treatment. A malaria test was done and came back positive. Due to the vomiting an with an additional diagnosis of sepsis, and inability to tolerate oral medication, Becky was admitted to the ward for close monitoring and appropriate management to support her recovery.

During her admission, Becky Anne was initiated on IV Artesunate 39 mg administered at 0 hours, 12 hours, and 24 hours. She also received oral Paracetamol syrup 5 mls three times daily for three days, IV Ceftriaxone 650 mg once daily for three days, and a PR Acetaminophen suppository 250 mg STAT. Additionally, she was started on oral Artemether-Lumefantrine (AL I) twice daily for three days. Becky Anne showed progressive clinical improvement and recovery during her hospital stay. She was subsequently discharged home on CTX syrup 5 mls twice daily for three days and Brufen syrup 5 mls twice daily for three days. A follow-up phone call later confirmed that she is doing well.

With prompt hospital admission and appropriate treatment, Becky’s prognosis is generally good. Early initiation of intravenous antimalarials, antibiotics, fluids, and supportive care significantly improves her chances of a full recovery. Becky is expected to respond well to treatment, regain her strength, and return to her usual playful and cheerful behavior once the malaria infection and sepsis are fully controlled.